Vaxart, Inc.
VXRT
$0.4945
-$0.038-7.14%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 37.48% | 207.82% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 37.48% | 207.82% | |||
| Cost of Revenue | 35.71% | 50.37% | |||
| Gross Profit | -32.12% | 26.29% | |||
| SG&A Expenses | 25.95% | -7.35% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 34.24% | 37.45% | |||
| Operating Income | -29.96% | 20.61% | |||
| Income Before Tax | -31.22% | 16.02% | |||
| Income Tax Expenses | -46.02% | 877.78% | |||
| Earnings from Continuing Operations | -30.09% | 14.88% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -30.09% | 14.88% | |||
| EBIT | -29.96% | 20.61% | |||
| EBITDA | -37.08% | 24.45% | |||
| EPS Basic | -29.79% | 14.86% | |||
| Normalized Basic EPS | -31.17% | 16.06% | |||
| EPS Diluted | -29.79% | 14.86% | |||
| Normalized Diluted EPS | -31.17% | 16.06% | |||
| Average Basic Shares Outstanding | 0.15% | 0.06% | |||
| Average Diluted Shares Outstanding | 0.15% | 0.06% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||